Skip to main content
. 2019 Sep 10;19:904. doi: 10.1186/s12885-019-6113-3

Fig. 2.

Fig. 2

The relationship patient-reported CAS-CIPN and nurse- reported CTCAE (Peripheral sensory neuropathy). **Significant difference between groups (p < 0.01). CAS-CIPN: Comprehensive Assessment Scale for Chemotherapy-Induced Peripheral Neuropathy in Survivors of Cancer; CTCAE: Common Terminology Criteria for Adverse Events